Skip to main content
Log in

Defect in cholesterol esterification associated with renal diseases

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Changes in lipidaemia and in cholesterol esterification rate were investigated in 65 patients with chronic mesangial glomerulonephritis (GN), and in 26 patients with polycystic kidneys (PL), as well as in age- and sex-matched control groups. As compared to the controls, a slightly significant increase in cholesterol and triglyceride concentrations was found only for the GN group, whereas the rate of cholesterol esterification showed a highly significant reduction in both groups of diseased subjects. The average values of molar esterification rate (MER) were, respectively, 75.4 and 61.6 μmole·l−1·h−1 for the GN and PL groups, the respective control values being 96.9 and 91.1. Fractional esterification rate (FER) reflecting the rate of cholesterol exchange between blood and tissues fell in the same two groups of patients to 4.38 and 4.40%·h−1, respectively (controls 6.93 and 6.17). Both the changes in cholesterol esterification rates and a relative increase in the ratio of unesterified to esterified cholesterol were found in patients with low as well as normal glomerular filtration rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Norbeck, H. E.: Serum lipoproteins in chronic renal failure.Acta Med. Scand. Suppl., 649, 7 (1981).

    Google Scholar 

  2. Franey, J. R., Amádor, A.: Serum cholesterol measurement based on ethanol extraction and ferric chloride-sulphuric acid.Clin. Chim. Acta, 21, 255 (1968).

    Article  PubMed  CAS  Google Scholar 

  3. Marcel, Y. L., Vezina, C. A.: A method for the determination of the initial role of reaction of lecithin: cholesterol acyltransferase in human plasma.Biochim. Biophys. Acta (Amst.),306, 497 (1973).

    PubMed  CAS  Google Scholar 

  4. Dobiášová, M., Kopecká, J., Živný, K.: The determination of cholesterol: lecithin acyltransferase. A modification of the method available for standard clinical use.Čas. Lék Čes., 117, 1394 (1978).

    Google Scholar 

  5. Glomest, J. A., Wright, J. L.: Some properties of a cholesterol-esterifying enzyme in human plasma.Biochim. Biophys. Acta (Amst.),89, 266 (1964).

    Google Scholar 

  6. Guarnieri, G. F., Morachiello, M., Companucci, L., Ursini, F., Ferri, L., Valenta, M., Gregolin, C.: Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uremia.Kidney Int., 13, (Suppl. 8), S26 (1978).

    Google Scholar 

  7. Jung, K., Neumann, R., Precht, K., Nugel, E., Scholz, D.: Lecithin: cholesterol acyltransferase activity, HDL-cholesterol and apolipoprotein A in serum of patients undergoing chronic haemodialysis.Enzyme, 273 (1980).

  8. Chan, M. K., Ramdial, L., Varghese, Z., Persand, J. W., Baillod, R. A., Moorhead, J. F.: Plasma lecithin-cholesterol acyltransferase activity in uremic patients.Clin. Chim. Acta, 119, 65 (1982).

    Article  PubMed  CAS  Google Scholar 

  9. McLeod, R., Reeve, C. E., Frohlich, J.: Plasma lipoproteins and lecithin: cholesterol acyltransferase distribution in patients on dialysis.Kidney Int., 25, 683 (1984).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Střibrná, J., Dobiášová, M., Prát, V. et al. Defect in cholesterol esterification associated with renal diseases. International Urology and Nephrology 19, 195–200 (1987). https://doi.org/10.1007/BF02550473

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550473

Keywords

Navigation